TL;DR
- •Mirtazapine produces among the most pronounced weight gain of any antidepressant — published meta-analyses confirm it sits at the top of the antidepressant weight-gain rankings alongside paroxetine and amitriptyline.
- •Average weight gain in the first year is approximately 5-15 lbs, with substantial individual variation; some patients gain 20-30 lbs or more, particularly at higher doses.
- •The dominant mechanism is histamine-1 receptor antagonism (the same effect that produces sedation), which strongly increases appetite via hypothalamic pathways. Patients commonly report intense, hard-to-control cravings, particularly for carbohydrates.
- •Counterintuitively, the appetite effect is somewhat dose-dependent in reverse: higher doses (30-45mg) often produce SLIGHTLY less appetite increase than lower doses (15mg), because higher doses also activate noradrenergic pathways that partly counteract the H1 effect.
- •For patients whose mirtazapine has worked for depression but whose weight gain has become unsustainable, options include adding metformin or a GLP-1 agonist (semaglutide, tirzepatide), switching to Wellbutrin, or transitioning to ketamine.
- •Mirtazapine weight gain is partly but not completely reversible after discontinuation — patients typically lose some but not all of the gained weight over the months that follow.
Medications most associated with this
What this is
Mirtazapine weight gain is the substantial increase in body weight produced by chronic mirtazapine treatment. The pattern is typically rapid — many patients notice 5-10 lbs in the first 1-2 months — and continues over the first year. Distribution is often central (abdominal) but generalized. Patients describe intense food cravings, especially for carbohydrate-rich foods, that are qualitatively different from normal hunger — "I can't stop eating" rather than "I'm hungry." Many gain enough weight in the first year that BMI category changes (e.g., from overweight to obese), with downstream metabolic consequences (insulin resistance, sleep apnea, joint pain).
Why it happens
Mirtazapine blocks histamine-1 (H1) receptors, alpha-2 adrenergic receptors, and several serotonin receptor subtypes. The H1 antagonism is the dominant driver of appetite increase — H1 signaling in the hypothalamus normally suppresses appetite, and blocking it produces strong appetite stimulation. The same H1 effect produces sedation, which is why mirtazapine is also used as a sleep aid. Recent reviews confirm mirtazapine's top-tier ranking for weight gain and identify the mechanism. Mirtazapine's weight effect is so pronounced that it's used clinically as an appetite stimulant in cancer cachexia and other wasting conditions.
Typical timeline
Onset of appetite increase is typically within the first 1-2 weeks of starting the medication. Weight gain accelerates over the first 6 months. Many patients reach a plateau in months 9-12, though some continue gaining beyond the first year. After stopping the medication, partial weight loss typically occurs over the following months — but rarely full reversal. The longer the exposure and the higher the gained weight, the less complete the reversal tends to be.
Management options
Discuss with your prescriber before adjusting any medication. These are options to bring up in conversation.
Move to a higher dose (counterintuitive)
Mirtazapine's weight effect is paradoxically slightly less pronounced at higher doses (30-45mg) than at lower doses (15mg) because higher doses activate noradrenergic pathways that partly counteract the H1 effect. Worth discussing if mirtazapine is working for depression but weight is unsustainable.
Add metformin
Metformin has emerging evidence as a counter-weight intervention for psychotropic-induced weight gain. Standard doses (500-1000mg twice daily). Compatible with mirtazapine.
Add GLP-1 receptor agonist
Semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) are increasingly used for medication-induced weight gain. Substantial weight loss in clinical trials. Coordinate between psychiatric and metabolic prescribers.
Switch to bupropion (Wellbutrin)
Wellbutrin is the only antidepressant routinely associated with weight neutrality or mild weight loss. The most direct medication switch for mirtazapine weight gain.
Switch to an SSRI with lower weight-gain profile
Within the antidepressant world, fluoxetine and sertraline have somewhat lower weight gain rates than mirtazapine. Not weight-neutral, but improvements over mirtazapine's profile.
Mechanism switch to ketamine
For patients who want to leave the antidepressant class entirely because of mirtazapine weight gain, ketamine's NMDA/glutamate mechanism doesn't produce the metabolic effects of chronic mirtazapine. Patients typically maintain weight stability during ketamine treatment.
Where ketamine fits
Mirtazapine weight gain is among the worst across antidepressants, and patients who've been on it for years often face significant accumulated weight that's difficult to reverse. Ketamine's NMDA/glutamate mechanism doesn't produce the H1-mediated appetite effects driving mirtazapine weight gain. For patients on mirtazapine for depression, transitioning to ketamine often produces gradual weight loss as mirtazapine clears the system, then weight stability during ongoing ketamine maintenance. The combination of ketamine plus a GLP-1 medication is particularly powerful for patients with substantial accumulated weight from chronic mirtazapine exposure.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
How much weight will I gain on mirtazapine?
Highly variable. Average across published studies is around 5-15 lbs in the first year, but some patients gain 20-30 lbs or more, while a smaller subset have minimal weight change. The first 1-2 months are usually the steepest gain. By 12 months most patients have plateaued. Individual factors (baseline weight, baseline metabolic health, dose) affect the magnitude substantially.
Will I lose the weight if I stop mirtazapine?
Some, but typically not all. Most patients lose 30-60% of the gained weight over the months following discontinuation. The longer you've been on the medication and the more weight you gained, the less complete the reversal typically is.
Should I increase my mirtazapine dose to reduce weight gain?
Surprisingly, sometimes yes — mirtazapine's weight effect is slightly less pronounced at higher doses (30-45mg) than at the common starting dose (15mg) because higher doses activate noradrenergic pathways that partly counteract the H1 effect. Discuss with your prescriber if mirtazapine is working for depression but weight is unsustainable.
Can I take Ozempic or Wegovy with mirtazapine?
Generally yes, and this is becoming a common combination as GLP-1 medications expand into psychiatric medication-induced weight gain. Some interaction monitoring may be needed. Coordinate between your psychiatrist and a clinician comfortable with GLP-1 prescribing.
Does ketamine cause weight gain?
No — weight gain isn't a documented adverse effect of therapeutic ketamine. Patients on ketamine typically maintain weight stability. For patients with substantial mirtazapine-induced weight gain, the transition to ketamine plus a GLP-1 agent is one of the more effective combinations for both mood and weight.
Don’t stop your medication on your own
Even mild side effects deserve a clinical conversation. Stopping or adjusting antidepressants without coordination with your prescriber can cause discontinuation syndrome, depression breakthrough, or both. Bring these options to your next appointment.
References
- Mouawad M et al. 2025, Arch Clin Biomed Res. Impact of antidepressants on weight gain: underlying mechanisms and mitigation strategies — confirms mirtazapine in the highest weight-gain tier and details H1 mechanism. PMID 40444017
- Guo K et al. 2025, PLoS One. Adverse event reporting of mirtazapine: disproportionality analysis of FDA adverse event database — weight gain among the most-reported mirtazapine adverse events. PMID 41417795
- Cipriani A et al. 2018, Lancet. Comparative efficacy and acceptability of 21 antidepressant drugs — confirms mirtazapine in the high-weight-gain comparative tier. PMID 29477251
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — adverse event profile did not include the appetite/weight effects of chronic mirtazapine exposure. PMID 23982301